Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.

Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis

Open access

Abstract

BACKGROUND: Several interventions are available for management of obsessive-compulsive disorder in adults, but few studies have compared their relative efficacy in a single analysis. We aimed to simultaneously compare all available treatments using both direct and indirect data. METHODS: In this systematic review and network meta-analysis, we searched the two controlled trials registers maintained by the Cochrane Collaboration Common Mental Disorders group for trials published up to Feb 16, 2016. We selected randomised controlled trials in which an active psychotherapeutic or pharmacological intervention had been used in adults with obsessive-compulsive disorder. We allowed all comorbidities except for schizophrenia or bipolar disorder. We excluded studies that focused exclusively on treatment-resistant patient populations defined within the same study. We extracted data from published reports. The primary outcome was symptom severity as measured by the Yale-Brown Obsessive Compulsive Scale. We report mean differences with 95% credible intervals compared with placebo. This study is registered with PROSPERO, number CRD42012002441. FINDINGS: We identified 1480 articles in our search and included 53 articles (54 trials; 6652 participants) in the network meta-analysis. Behavioural therapy (mean difference -14·48 [95% credible interval -18·61 to -10·23]; 11 trials and 287 patients), cognitive therapy (-13·36 [-18·40 to -8·21]; six trials and 172 patients), behavioural therapy and clomipramine (-12·97 [-19·18 to -6·74]; one trial and 31 patients), cognitive behavioural therapy and fluvoxamine (-7·50 [-13·89 to -1·17]; one trial and six patients), cognitive behavioural therapy (-5·37 [-9·10 to -1·63]; nine trials and 231 patients), clomipramine (-4·72 [-6·85 to -2·60]; 13 trials and 831 patients), and all SSRIs (class effect -3·49 [95% credible interval -5·12 to -1·81]; 37 trials and 3158 patients) had greater effects than did drug placebo. Clomipramine was not better than were SSRIs (-1·23 [-3·41 to 0·94]). Psychotherapeutic interventions had a greater effect than did medications, but a serious limitation was that most psychotherapeutic trials included patients who were taking stable doses of antidepressants (12 [80%] of the 15 psychotherapy trials explicitly allowed antidepressants). INTERPRETATION: A range of interventions is effective in the management of obsessive-compulsive disorder, but considerable uncertainty and limitations exist regarding their relative efficacy. Taking all the evidence into account, the combination of psychotherapeutic and psychopharmacological interventions is likely to be more effective than are psychotherapeutic interventions alone, at least in severe obsessive-compulsive disorder. FUNDING: National Institute for Health Research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(16)30069-4

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study selection YBOCS=Yale-Brown Obsessive Compulsive Scale.
Figure 1 Study selection YBOCS=Yale-Brown Obsessive Compulsive Scale.CC BY · PubMed Central
Figure 2 Network diagram for efficacy analysis representing direct comparisons between individual treatments The size of each circle is proportional to the number of randomly allocated participants and the width of each line is proportional to the number of trials in each direct comparison. BT=behavioural therapy. CBT=cognitive behavioural therapy. CT=cognitive therapy. BTCLO=behavioural therapy and clomipramine. CBTFLV=cognitive behavioural therapy and fluvoxamine. CIT=citalopram. CLO=clomipramine. ESCIT=escitalopram. FLV=fluvoxamine. FLX=fluoxetine. HYP=hypericum. PAR=paroxetine. PL=placebo. PSYPL=psychological placebo. SER=sertraline. VEN=venlafaxine. WL=waiting list.
Figure 2 Network diagram for efficacy analysis representing direct comparisons between individual treatments The size of each circle is proportional to the number of randomly allocated participants and the width of each line is proportional to the number of trials in each direct comparison. BT=behavioural therapy. CBT=cognitive behavioural therapy. CT=cognitive therapy. BTCLO=behavioural therapy and clomipramine. CBTFLV=cognitive behavioural therapy and fluvoxamine. CIT=citalopram. CLO=clomipramine. ESCIT=escitalopram. FLV=fluvoxamine. FLX=fluoxetine. HYP=hypericum. PAR=paroxetine. PL=placebo. PSYPL=psychological placebo. SER=sertraline. VEN=venlafaxine. WL=waiting list.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 89 references

Research works printed but not linked: 2

  1. Jenike, 1990, Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo, Am J Psychiatry, 147, 923
  2. Nakajima, 1996, Clinical usefulness of fluvoxamine maleate (SME3110), a selective serotonin reuptake inhibitor, in the treatment of obsessive compulsive disorder: a double blind, placebo controlled study, J Clin Therapeut Med, 12, 409

Cited by

See all 421

Metadata

Authors
Skapinakis, P., Caldwell, D. M., Hollingworth, W., Bryden, P., Fineberg, N. A., Salkovskis, P., Welton, N. J., Baxter, H., Kessler, D., Churchill, R., & Lewis, G.
Affiliations
  • University of Ioannina (GR)
  • University of Bristol (GB)
  • University of Hertfordshire (GB)
  • University of Bath (GB)
  • University of York (GB)
  • University College London (GB)
Corresponding author
Skapinakis, Petros
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2016-08
Volume
3
Issue
8
Pages
730-739
ISSN
2215-0366 (ISSN-L)
OpenAlex
W2423509797
Cited by
407
References
89
Citations by year
2026: 35 · 2025: 51 · 2024: 46 · 2023: 50 · 2022: 44 · 2021: 45 · 2020: 43 · 2019: 37 · 2018: 29 · 2017: 16 · 2016: 10
FWCI
4.54
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • University of Hertfordshire Research Archive (University of Hertfordshire) (acceptedVersion)
  • University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion, cc-by)
  • UCL Discovery (University College London) (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by)
Funders
Health Technology Assessment Programme (10/104/41)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
obsessive-compulsive disorder, pharmacotherapy, psychotherapy, clomipramine, selective serotonin reuptake inhibitors, fluvoxamine, cognitive behavioral therapy, behavior therapy, cognitive therapy, Yale-Brown Obsessive Compulsive Scale, symptom severity, treatment efficacy comparison, adults, comorbid depression, anxiety comorbidity, comorbid substance use disorders
MeSH terms
Adult, Humans, Obsessive-Compulsive Disorder, Psychotherapy, Psychotropic Drugs, Randomized Controlled Trials as Topic, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. https://app.cochat.ai/papers/10.1016/s2215-0366(16)30069-4
The paper
Skapinakis, P., Caldwell, D. M., Hollingworth, W., Bryden, P., Fineberg, N. A., Salkovskis, P., Welton, N. J., Baxter, H., Kessler, D., Churchill, R., & Lewis, G. (2016). Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(16)30069-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.